IP Library Granted Patent US 9,421,306
Granted Patent B2
US 9,421,306 · App. 13/616,556 · Granted Aug 23, 2016

Reinforced biologic material

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,421,306
App. No.
13/616,556
Granted
Aug 23, 2016
Kind
B2
Abstract

The present disclosure provides an implantable medical device comprising a composite graft material including a first biologic component, such as an acellular tissue matrix, and a second non-biologic component.

Claims (27)

1. An implantable medical device, comprising:

a plurality of first elongate non-biologic elements, at least a portion of which are under a tensile or compressive stress prior to implantation;

at least one biologic component comprising a biomatrix surrounding at least a portion of the plurality of first elongate non-biologic elements; and

at least one second elongate non-biologic element, wherein the at least one second element secures at least one end portion of the plurality of first elongate non-biologic elements;

wherein the plurality of first elongate non-biologic elements have a higher load capacity than the at least one biologic component at the time of implantation; and

wherein the at least one biologic component has a higher load capacity than the plurality of first elongate non-biologic elements after implantation and following growth of native cells within the biomatrix.

2. The implantable medical device of claim 1 , wherein the plurality of first elongate non-biologic elements comprises at least one material chosen from bioabsorbable polymer, bioabsorbable metal, or a combination of bioabsorbable polymer and bioabsorbable metal.

3. The implantable medical device of claim 1 , wherein the plurality of first elongate non-biologic elements comprise at least one material chosen from polyhydroxyalkanoate, poly-hydroxybutyrate, polylactic acid (PLA), polyglycolic acid (PGA), polylactideglycolide acid (PLGA), polydioxanone (PDO), polycaprolactone (PCL), a polyanhydride, a polyorthoester, a poly(amino acid), a polypeptide, a polydepsipeptide, a nylon-2/nylon-6 copolyamide, a poly(alkylene succinate), poly(hydroxyl butyrate) (PHB), poly(butylene diglocolate), poly(.epsilon.-caprolactone), a polydihydropyran, a polyphosphazene, a poly(cyano acrylates), modified polysaccharides, cellulose, starch, chitin, modified proteins, collagen, fibrin, and combinations and copolymers thereof.

4. The implantable medical device of claim 1 , wherein the biomatrix comprises an acellular tissue matrix or a particulate acellular tissue matrix.

5. The implantable medical device of claim 1 , wherein the plurality of first elongate non-biologic elements comprises a bioabsorbable polymer, a bioabsorbable metal or a combination of a bioabsorbable polymer and bioabsorbable metal.

6. The implantable medical device of claim 1 , wherein the plurality of first elongate non-biologic elements are under a tensile stress ranging from greater than 0 N to about 1800 N.

7. The implantable medical device of claim 1 , wherein the plurality of first elongate non-biologic elements comprises a plurality of threads, cords, cables, ribbons, or braids.

8. The implantable medical device of claim 1 , wherein the at least one biologic component at least partially separates the elongate first elements comprised within the plurality of elongate first non-biologic elements.

9. The implantable medical device of claim 1 , wherein the at least one biologic component at least partially coats each element comprised within the plurality of first elongate non-biologic elements.

10. The implantable medical device of claim 1 , wherein the at least one biologic component is in the form of a coating, a paste, a powder, or a liquid.

11. The implantable medical device of claim 1 , wherein the at least one second elongate non-biologic element secures at least one end of the plurality of first elongate non-biologic elements by at least one of whipping, wrapping, and winding.

12. The implantable medical device of claim 1 , wherein the at least one second elongate non-biologic element comprises the same material as the plurality of first elongate non-biologic elements.

13. The implantable medical device of claim 1 , wherein at least a portion of the plurality of first elongate non-biologic elements are under a longitudinal tensile or compressive stress prior to implantation.

14. The implantable medical device of claim 1 , wherein at least a portion of the plurality of first elongate non-biologic elements are under a tensile or compressive stress of at least about 0.1 N prior to implantation.

15. The implantable medical device of claim 1 , wherein at least a portion of the plurality of first elongate non-biologic elements are under a tensile or compressive stress ranging from about 0.1 N to about 1800 N prior to implantation.

16. An implantable medical device, comprising:

a plurality of first elongate non-biologic elements, at least a portion of which are under a tensile or compressive stress prior to implantation;

at least one biologic component comprising a biomatrix surrounding at least a portion of the plurality of first elongate non-biologic elements; and

at least one second elongate non-biologic element, wherein the at least one second element secures at least one end portion of the plurality of first elongate non-biologic elements;

wherein the plurality of first elongate non-biologic elements have a higher load capacity than the at least one biologic component at the time of implantation;

wherein the at least one biologic component has a higher load capacity than the plurality of first elongate non-biologic elements after implantation and following growth of native cells within the biomatrix; and

wherein the at least one second elongate non-biologic element forms a screw-thread pattern compatible with threads of an anchoring screw.

Assignments (8)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 25, 2021
From: KIEFER, ROBERT A.; GREENHALGH, E. SKOTT
To: STOUT MEDICAL GROUP, L.P.
Reel/Frame 055427/0943 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 22, 2021
From: LIFECELL CORPORATION
To: STOUT MEDICAL GROUP, L.P.
Reel/Frame 055359/0582 →
RELEASE OF SECURITY INTEREST 037845/0497 Recorded Feb 2, 2017
From: WILMINGTON TRUST
To: LIFECELL CORPORATION
Reel/Frame 041608/0603 →
RELEASE OF SECURITY INTEREST 040098/0268 Recorded Feb 2, 2017
From: WILMINGTON TRUST
To: LIFECELL CORPORATION
Reel/Frame 041608/0554 →
RELEASE OF SECURITY INTEREST 040291/0237 Recorded Feb 2, 2017
From: WILMINGTON TRUST
To: LIFECELL CORPORATION
Reel/Frame 041608/0702 →
LIMITED THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Oct 7, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040291/0237 →
SECOND LIEN SECURITY AGREEMENT Recorded Sep 21, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040098/0268 →
SECURITY INTEREST Recorded Feb 17, 2016
From: KINETIC CONCEPTS, INC.; KCI USA, INC.; ACELITY L.P. INC.; CHIRON HOLDINGS, INC.; CHIRON TOPCO, INC.; KCI ANIMAL HEALTH, LLC; KCI HOLDING COMPANY, INC.; KCI HOMECARE, INC.; KCI IMPORTS, INC.; KCI INTERNATIONAL, INC.; KCI LICENSING, INC.; KCI PROPERTIES LIMITED; KCI REAL HOLDINGS, L.L.C.; KCI REAL PROPERTY LIMITED; KCI USA REAL HOLDINGS, L.L.C.; LIFECELL CORPORATION; TECHNIMOTION, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 037845/0497 →